433 related articles for article (PubMed ID: 25797678)
1. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
[TBL] [Abstract][Full Text] [Related]
2. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
Ma Y; Halade GV; Zhang J; Ramirez TA; Levin D; Voorhees A; Jin YF; Han HC; Manicone AM; Lindsey ML
Circ Res; 2013 Feb; 112(4):675-88. PubMed ID: 23261783
[TBL] [Abstract][Full Text] [Related]
4. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
6. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
7. Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality.
Lindsey ML; Jung M; Yabluchanskiy A; Cannon PL; Iyer RP; Flynn ER; DeLeon-Pennell KY; Valerio FM; Harrison CL; Ripplinger CM; Hall ME; Ma Y
Cardiovasc Res; 2019 Feb; 115(2):395-408. PubMed ID: 30169632
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
9. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.
Jung M; Ma Y; Iyer RP; DeLeon-Pennell KY; Yabluchanskiy A; Garrett MR; Lindsey ML
Basic Res Cardiol; 2017 May; 112(3):33. PubMed ID: 28439731
[TBL] [Abstract][Full Text] [Related]
10. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.
Takahashi T; Anzai T; Kaneko H; Mano Y; Anzai A; Nagai T; Kohno T; Maekawa Y; Yoshikawa T; Fukuda K; Ogawa S
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1795-804. PubMed ID: 20852043
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
[TBL] [Abstract][Full Text] [Related]
15. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
Kandalam V; Basu R; Abraham T; Wang X; Awad A; Wang W; Lopaschuk GD; Maeda N; Oudit GY; Kassiri Z
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1012-23. PubMed ID: 20675565
[TBL] [Abstract][Full Text] [Related]
16. Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.
Spinale FG; Escobar GP; Hendrick JW; Clark LL; Camens SS; Mingoia JP; Squires CG; Stroud RE; Ikonomidis JS
J Pharmacol Exp Ther; 2006 Sep; 318(3):966-73. PubMed ID: 16757539
[TBL] [Abstract][Full Text] [Related]
17. A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.
Lindsey ML; Iyer RP; Zamilpa R; Yabluchanskiy A; DeLeon-Pennell KY; Hall ME; Kaplan A; Zouein FA; Bratton D; Flynn ER; Cannon PL; Tian Y; Jin YF; Lange RA; Tokmina-Roszyk D; Fields GB; de Castro Brás LE
J Am Coll Cardiol; 2015 Sep; 66(12):1364-74. PubMed ID: 26383724
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
19. Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Gong W; Ma Y; Li A; Shi H; Nie S
Cardiovasc Ther; 2018 Oct; 36(5):e12460. PubMed ID: 30019466
[TBL] [Abstract][Full Text] [Related]
20. Splenic Ly6C
Tomczyk M; Kraszewska I; Szade K; Bukowska-Strakova K; Meloni M; Jozkowicz A; Dulak J; Jazwa A
Basic Res Cardiol; 2017 Jul; 112(4):39. PubMed ID: 28534119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
